Why SARS-CoV-2 replicates better in the upper respiratory tract

31-Mar-2021 5:25 PM EDT, by University of Bern

Newswise — "SARS-CoV-2 and SARS-CoV are highly similar genetically, generate a homologous repertoire of viral proteins, and use the same receptor to infect human cells. However, despite these similarities, there are also important differences between the two viruses", says Ronald Dijkman from the Institute for Infectious Diseases (IFIK) at the University of Bern. For example, SARS-CoV infection is characterized by severe disease and inflammation in the lower respiratory tract and infected individuals are only contagious after the onset of symptoms, making it easier to identify and interrupt infection chains.

In contrast, SARS-CoV-2 preferentially replicates in the upper airways (nasal cavity, pharynx, trachea) and can be efficiently transmitted from one individual to another before the appearance of disease symptoms. Moreover, the outcome of SARS-CoV-2 infection varies widely from person to person, and can manifest as asymptomatic, mild, or severe disease. Older people as well as individuals with certain underlying medical conditions (heart conditions, diabetes, cancer) are at greater risk of developing severe illness, which is often associated with infection of lower respiratory tissues, high levels of inflammation, and lung failure.

Temperature is key

To better understand why infections with SARS-CoV and SARS-CoV-2 result in such different clinical outcomes, researchers from the University of Bern used specialized human airway cell cultures to investigate the impact of respiratory tract temperatures on SARS-CoV and SARS-CoV-2 replication. The cells originate from human samples and mimic the complexity of the cells found in the respiratory tract. They grow in special containers, are nourished from the bottom side and are exposed to air on the top side, just like the cells in the human trachea. The cultures also make mucus and have cilia that beat very quickly. "Because the organization of these cells greatly resembles the cells found in human tissues, they are a relevant system that can be used in a laboratory to study respiratory viruses", Dijkman explains.

The researchers have now used this existing model for the first time to study the effects of respiratory temperatures on SARS-CoV and SARS-CoV-2 replication. They found that temperature plays an important role as SARS-CoV-2 preferred to replicate at temperatures typically found in the upper airways (33°C). Colder incubation temperatures allowed the virus to replicate faster and to a higher extent than when infections were carried out at 37°C to mimic the lower lung environment. Unlike SARS-CoV-2, replication of SARS-CoV was not impacted by different incubation temperatures. The experiments were conducted both in the high security laboratory of the IVI in Mittelhäusern and in the biosafety laboratory of the Institute for Infectious Diseases (IFIK) at the University of Bern in the building of sitem-insel, the Swiss Institute for Translational Medicine and Entrepreneurship.

Temperature also influences the response from the epithelium

The team also analyzed which genes are turned on and off after infection with SARS-CoV and SARS-CoV-2 to understand how cells from the human respiratory tract respond to infection and which innate immune programs are activated. The innate immune system is our body's "first line of defense" against invading pathogens and is crucial not only to contain the invader, but also to teach other branches of the immune system how to react appropriately.

When mimicking the conditions found in the upper airways (33°C), the team found that infection with SARS-CoV-2 did not stimulate the innate immune response within these cells as strongly as it did when they mimicked conditions found in the lower respiratory tract (37°C). "Since the strength of the innate immune response can directly influence the degree of viral replication, this may help explain why SARS-CoV-2 replicated more efficiently at lower temperatures", says Dijkman. Although mounting a strong innate immune response against the virus is generally beneficial, it is important to note that in some cases the innate immune response can become overactivated. This in turn can be detrimental to the infected individual, as high levels of inflammation can also induce tissue damage and accelerate disease progression - a phenomenon that is often seen in patients suffering from severe COVID19.

"The detailed analysis of SARS-CoV-2 replication and the temperature-induced changes in the host innate immune defense mechanisms helps explain why SARS-CoV-2 replicates so well in the upper respiratory tract, and is perhaps why SARS-CoV-2 exhibits higher human-to-human transmissibility than SARS-CoV", Dijkman explains.

Important knowledge to fight coronavirus infections

The use of this authentic cell culture model in a controlled laboratory setting proved to accurately reflect the different behavior of two similar viruses in the context of a pandemic. "This unique system provides insight into the molecular battle that occurs between virus and host during an infection and underscores the importance of subtle changes in the virus-host microenvironment that may impact virus replication and propagation", says Dijkman. Understanding which key players are involved in this process, and whether they favor the host or virus, opens new opportunities for the establishment of highly targeted intervention strategies and the development of novel pharmaceutical compounds that will help combat coronavirus infections.

###

This work was supported by the European Commission (Marie Sklodowska-Curie Innovative Training Network "HONOURS"), the Swiss National Science Foundation SNSF (Special call on Coronaviruses), and the German Federal Ministry of Education and Research, project RAPID.

Institute for Infectious Diseases (IFIK)

The IFIK is part of the Faculty of Medicine at the University of Bern, and combines diagnostic services, teaching and research in the fields of virology, bacteriology, mycology, parasitology and immunological infection analysis. The IFIK also houses the Biosafety Centre which assists research with highly pathogenic microorganisms. The research of the Experimental Virology Group at the IFIK is focused on investigating how emerging respiratory pathogens, including influenza viruses and coronaviruses, transmit from animals to humans.
https://www.ifik.unibe.ch/

Institute of Virology and Immunology (IVI)

The IVI is Switzerland's reference laboratory for the diagnosis, monitoring and research of highly infectious epizootic diseases, including viral zoonoses (infectious diseases that are transmissible between animals and humans). The IVI is also responsible for the approval and monitoring of animal vaccines and immune sera for use in veterinary medicine. As part of a cooperation agreement with the Vetsuisse faculty of the University of Bern, the IVI is also responsible for teaching and research in the fields of virology and immunology. Research activities encompass both basic and applied research and provide an important basis for the control of epizootic diseases and zoonoses. The IVI reports to the Federal Food Safety and Veterinary Office (FSVO).
https://www.ivi.unibe.ch/

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 5849
Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
VIDEO
Released: 18-Jun-2021 2:10 PM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available
Newswise

Newswise is hosting a series of Expert Panels discussion on unique aspects of the COVID-19 pandemic. This tip sheet includes some notable quotes from the panelists.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Jun-2021 8:00 AM EDT Released to reporters: 18-Jun-2021 11:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2021 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded virtual-event-for-june-17-11am-edt-covid-19-vaccines-and-male-fertility
VIDEO
Released: 18-Jun-2021 8:55 AM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Vaccines and Male Fertility Event for June 17, 2021
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Jun-2021 11:00 AM EDT Released to reporters: 18-Jun-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Jun-2021 7:05 AM EDT
Teamwork saves lives: COVID-19 hospital network shares key findings to improve care
Michigan Medicine - University of Michigan

Data sharing among 40 Michigan hospitals about the care and outcomes for thousands of inpatients with COVID-19 has led to reduced variation and findings that could inform care anywhere, including approaches for preventing blood clots and reducing overuse of antibiotics, as well as a risk prediction tool.

Released: 18-Jun-2021 7:05 AM EDT
One-third of older Americans delayed health care over COVID concerns
Michigan Medicine - University of Michigan

Nearly one in three Americans between the ages of 50 and 80 put off an in-person appointment for medical care in 2020 because they were worried about exposure to the novel coronavirus, new national poll data show.

Released: 17-Jun-2021 4:15 PM EDT
UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients
University of North Carolina School of Medicine

Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring hospitalization and intensive care. A new study shows best treatment options.

Released: 17-Jun-2021 4:10 PM EDT
Vaccination, Previous Infection, Protect Against COVID-19 gamma/P.1 Variant in Animal Model
University of Wisconsin-Madison

In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.

Released: 17-Jun-2021 1:30 PM EDT
Hackensack Meridian Doctors, Student Help Establish Way to Prioritize Surgeries During COVID-19 lockdown
Hackensack Meridian Health

The MeNTS method of prioritizing surgeries during the height of pandemic, developed by University of Chicago, helped procedures continue during time of need

Released: 17-Jun-2021 12:55 PM EDT
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
North Carolina State University

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.


Showing results

110 of 5849

close
1.57925